Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yael Flamand

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2022
Reply to A.S. GardenRobert L Ferris, Barbara Burtness, Yael Flamand
Leukemia & Lymphoma|September 16, 2024
Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidationEvan C Chen, Yael Flamand, Emily Tiao, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 17, 2025
Utility of ursodiol prophylaxis against sinusoidal obstruction syndrome (SOS)/ veno-occlusive disease (VOD) in acute leukemia patients receiving gemtuzumab-ozogamicin (GO) or inotuzumab-ozogamicin (InO)Grace Mosallam, Eric S Winer, Julia H Keating, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 25, 2021
Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated PancreatitisErin E Mauney, Alexandra Power-Hays, Yael Flamand, et al.
Pediatric Blood & Cancer|December 21, 2021
Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administrationNetanya I Pollock, Yael Flamand, Jia Zhu, et al.
Pediatric Blood & Cancer|June 30, 2021
PediCARE: Development of a poverty-targeted intervention for pediatric cancerPuja J Umaretiya, Anna Revette, Anna Seo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2024
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305Athanassios Argiris, Yael Flamand, Panayiotis Savvides, et al.
Cardio-Oncology (London, England)|November 4, 2025
Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemiaVernon E Walker, Neha Bansal, Salina M Torres, et al.
Frontiers in Pediatrics|January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocolsGiacomo Gotti, Yael Flamand, Victoria Koch, et al.
American Journal of Hematology|April 10, 2021
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following inductionJ Erika Haydu, Yael Flamand, Rahul S Vedula, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2022
Reply to A.S. GardenRobert L Ferris, Barbara Burtness, Yael Flamand
Leukemia & Lymphoma|September 16, 2024
Incidence, duration, and severity of neutropenia in adults with B-cell acute lymphoblastic leukemia receiving blinatumomab consolidationEvan C Chen, Yael Flamand, Emily Tiao, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|January 17, 2025
Utility of ursodiol prophylaxis against sinusoidal obstruction syndrome (SOS)/ veno-occlusive disease (VOD) in acute leukemia patients receiving gemtuzumab-ozogamicin (GO) or inotuzumab-ozogamicin (InO)Grace Mosallam, Eric S Winer, Julia H Keating, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 25, 2021
Clinical Characteristics and Short-Term Outcomes of Children With Asparaginase-Associated PancreatitisErin E Mauney, Alexandra Power-Hays, Yael Flamand, et al.
Pediatric Blood & Cancer|December 21, 2021
Hyperglycemia during induction therapy for acute lymphoblastic leukemia is temporally linked to pegaspargase administrationNetanya I Pollock, Yael Flamand, Jia Zhu, et al.
Pediatric Blood & Cancer|June 30, 2021
PediCARE: Development of a poverty-targeted intervention for pediatric cancerPuja J Umaretiya, Anna Revette, Anna Seo, et al.
European Journal of Cancer (Oxford, England : 1990)|January 12, 2024
A new prognostic model in chemotherapy-treated patients with recurrent or metastatic head and neck cancer: An analysis of ECOG-ACRIN E1305Athanassios Argiris, Yael Flamand, Panayiotis Savvides, et al.
Cardio-Oncology (London, England)|November 4, 2025
Mutational analysis of the mitochondrial tRNA genes and flanking regions in lymphocytes from long-term pediatric cancer survivors given doxorubicin chemotherapy for acute lymphoblastic leukemiaVernon E Walker, Neha Bansal, Salina M Torres, et al.
Frontiers in Pediatrics|January 28, 2026
Outcomes of T-cell lymphoblastic lymphoma in children and adolescents treated with Dana-Farber Cancer Institute Childhood ALL Consortium protocolsGiacomo Gotti, Yael Flamand, Victoria Koch, et al.
American Journal of Hematology|April 10, 2021
Pretreatment clinical and genetic factors predict early post-treatment mortality in fit AML patients following inductionJ Erika Haydu, Yael Flamand, Rahul S Vedula, et al.
Pageof 4